Hyaluronic acid, transforming growth factor-β1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection

Journal of Viral Hepatitis

Volumn 16, Issue 7, 2009, Pages 513-518

  Sanvisens, A ^a   Serra, I ^b   Tural, C ^a   Tor, J ^a   Ojanguren, I ^b   Barluenga, E ^b   Rey Joly, C ^a   Clotet, B ^a   Muga, R ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Fibrosis markers; HCV; HIV; Hyaluronic acid; TGF 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; BIOPSY; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; HYALURONIC ACID; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67650456394     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01103.x     Document Type: Article

References (29)

1. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999 30 : 1054 1058. (Pubitemid 29458296)
2. Pineda JA, García-García JA, Aguilar-Guisado M et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 2007 46 : 622 630. (Pubitemid 47436106)
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005 115 : 209 218. (Pubitemid 40385459)
4. Friedman SL, Rockey DC, Bissell DM. Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology 2007 45 : 242 249. (Pubitemid 46144384)
5. Knittel T, Ramadori G. Molecular biology. Curr Opin Gastroenterol 1995 11 : 258 266.
6. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993 328 : 1828 1835.
7. Gressner OA, Weiskirchen R, Gressner AM. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 2007 6 : 7.
8. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000 275 : 2247 2250. (Pubitemid 30081976)
9. Knittel T, Janneck T, Muller L, Fellmer P, Ramadori G. Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology 1996 24 : 352 360. (Pubitemid 26260031)
10. Okuda M, Li K, Beard MR et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002 122 : 366 375. (Pubitemid 34116988)
11. Alexandrow MG, Moses HL. Transforming growth factor-beta and cell cycle regulation. Cancer Res 1995 55 : 1452 1457.
12. Gressner AM, Schaffer S. Comparison of sulphated glycoamino-glycan and hyahtronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells. J Clin Chem Biothem 1989 27 : 141 149. (Pubitemid 19085761)
13. Eriksson S, Fraser JRE, Laurent TC, Pertorf H, Smedsrod B. Endothelial cells are the site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983 144 : 223 228.
14. Plevris JN, Haydon GH, Simpson KJ et al. Serum hyaluronan - a non invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol 2000 12 : 1121 1127. (Pubitemid 30786470)
15. Wong VS, Hughes V, Trull A, Wight DGD, Petrik J, Alexander JM. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatits C virus infection. J Viral Hepat 1998 5 : 187 192. (Pubitemid 28374728)
16. Guéchot J, Serfaty L, Bonnard AM, Chazouilleres O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensed HCV cirrhosis. J Hepatol 2000 32 : 447 452. (Pubitemid 30136860)
17. Patel K, Lajoie A, Heaton S et al. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol 2003 18 : 253 257. (Pubitemid 36513153)
18. Wai CW, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 526. (Pubitemid 36919874)
19. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002 36 : 986 992.
20. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43 : 1317 1325. (Pubitemid 43980111)
21. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991 13 : 372 374.
22. Czaja MJ, Weiner FR, Flanders KC. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol 1989 108 : 2477 2482. (Pubitemid 19168936)
23. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999 30 : 77 87. (Pubitemid 29023655)
24. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 2007 22 (Suppl. 1 S73 S78.
25. Sanz S, Pucilowska JB, Liu S et al. Expression of insulin-like growth factor-1 by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 2005 54 : 134 141. (Pubitemid 40007233)
26. El-Bassiouny AE, Zoheiry MM, Nosseir MM, El-Ahwany EG, Ibrahim RA, El-Bassiouni NE. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma. Med Gen Med 2007 9 : 45.
27. Nelson DR, Gonzalez-Peralta RP, Qian K et al. Transforming growth factor-B in chronic hepatitis C. J Viral Hepat 1997 4 : 29 35.
28. Kanzeler S, Baumann M, Schirmacher P et al. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-B. J Viral Hepat 2001 8 : 430 437. (Pubitemid 35013568)
29. Larrousse M, Laguno M, Segarra M et al. Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr 2007 46 : 304 311. (Pubitemid 350287357)